Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

10/31/2024 | Press release | Distributed by Public on 10/30/2024 17:29

VOLUNTARY ANNOUNCEMENT NEW DRUG APPLICATION FOR CORE PRODUCT SACITUZUMAB TIRUMOTECAN (SAC-TMT) ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION